German American Bancorp Inc. Has $5.17 Million Stock Position in Danaher Co. (NYSE:DHR)

German American Bancorp Inc. raised its stake in Danaher Co. (NYSE:DHR) by 5.8% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 18,584 shares of the conglomerate’s stock after buying an additional 1,022 shares during the period. German American Bancorp Inc.’s holdings in Danaher were worth $5,167,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. CarsonAllaria Wealth Management Ltd. bought a new stake in shares of Danaher during the 2nd quarter valued at about $25,000. nVerses Capital LLC bought a new position in shares of Danaher during the 2nd quarter worth approximately $25,000. MidAtlantic Capital Management Inc. purchased a new position in Danaher in the third quarter worth $40,000. MFA Wealth Advisors LLC purchased a new stake in Danaher during the second quarter worth about $51,000. Finally, Financial Connections Group Inc. purchased a new stake in shares of Danaher during the 2nd quarter worth approximately $51,000. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 1.0 %

Shares of DHR opened at $233.10 on Thursday. Danaher Co. has a 1-year low of $213.61 and a 1-year high of $281.70. The firm has a market capitalization of $168.36 billion, a price-to-earnings ratio of 44.48, a PEG ratio of 4.25 and a beta of 0.85. The firm’s 50-day moving average price is $259.67 and its 200-day moving average price is $260.13. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the previous year, the business posted $2.02 EPS. The company’s quarterly revenue was up 3.1% on a year-over-year basis. Sell-side analysts anticipate that Danaher Co. will post 7.5 EPS for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.46%. Danaher’s dividend payout ratio is presently 20.61%.

Analysts Set New Price Targets

Several analysts have recently issued reports on DHR shares. Evercore ISI boosted their price target on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Leerink Partners lifted their price target on Danaher from $275.00 to $280.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Stephens reiterated an “overweight” rating and issued a $315.00 target price on shares of Danaher in a research report on Wednesday, October 23rd. Royal Bank of Canada reduced their price target on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Finally, Raymond James decreased their price objective on Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $287.16.

Insider Buying and Selling

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. This trade represents a 18.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 11.10% of the stock is owned by company insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.